home All News open_in_new Full Article

Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025

LEXINGTON, Mass. — Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the Company will host a virtual Stakeholder Briefing on August 27, 2025 at 4:00 p.m. ET. The event will feature presentations from senior management and industry thought leaders, offering insights into transformative developments that could shape the future of cancer […]


today 3 w. ago attach_file Other

attach_file Science
attach_file Other
attach_file Other
attach_file Other
attach_file Society
attach_file Economics
attach_file Society
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 3287987523
Add Watch Country

arrow_drop_down